A research team investigating the use of the bacterium Listeria monocytogenes against colorectal cancer has discovered a way to build a modified version of Listeria as an oral vaccine to prime the ...

(NEW YORK) — A new study in the New England Journal of Medicine suggests that some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug ...

Metastatic kidney tumors disappearing for good. When the Food and Drug Administration approved the first immunotherapy for cancer in 2011, it ushered in a new era for care. Patients had a reason for ...

Maureen Sideris, seated, with her sister Marion, receiving the 8th of 9 immunotherapy infusions during successful treatment for early-stage gastroesophageal junction cancer at Memorial Sloan Kettering ...

Researchers say study results provide a clear rationale for developing therapies that target LCN2 in lung cancer patients.

Please provide your email address to receive an email when new articles are posted on . High-cost immunotherapy was associated with increased likelihood of being unable to afford medical care and ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...